Physician profile
Natalie Arnoff
NPI 1891715306
$1,734.42
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $512 · 2021: $724 · 2022: $125.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $499.98 | 2020-2022 | |
| Abbvie INC. | $249.99 | 2021 | |
| Janssen Pharmaceuticals, INC | $241.85 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $226.58 | 2019-2021 | |
| Allergan, INC. | $125.00 | 2020 | |
| Pharmacosmos Therapeutics INC. | $122.23 | 2021 | |
| Amarin Pharma, INC. | $105.38 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $70.61 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.46 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $19.63 | 2019 | |
| Novo Nordisk INC | $18.71 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natalie Arnoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.